Tearsheet

Talkspace (TALK)


Market Price (12/18/2025): $3.45 | Market Cap: $573.4 Mil
Sector: Health Care | Industry: Health Care Technology

Talkspace (TALK)


Market Price (12/18/2025): $3.45
Market Cap: $573.4 Mil
Sector: Health Care
Industry: Health Care Technology

Investment Highlights Why It Matters Which of these 2 stories sounds closer for this stock?

1. Generates cash flow

The stock generated 4% or more of the share price (called cash flow yield), and shows moderate 10-15% or more growth.

2. Riding a trend

Think Tesla during the pandemic of 2020 when EVs were riding a cultural high, or Nvidia in the current AI boom, or even Figma. These companies don’t have enough yield, or, enough growth, or both - however - they are riding a trend. They have momentum. These can be more volatile - they don’t have the floor of strong cash flow


0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -20%
Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -0.1 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -0.1%
1 Megatrend and thematic drivers
Megatrends include Digital Health & Telemedicine. Themes include Telehealth Platforms.
Expensive valuation multiples
P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 63x, P/EPrice/Earnings or Price/(Net Income) is 108x
2  Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.2%
3  Key risks
TALK key risks include [1] challenges in maintaining and expanding its network of therapists, Show more.
0 Cash is significant % of market cap
Net D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is -20%
1 Megatrend and thematic drivers
Megatrends include Digital Health & Telemedicine. Themes include Telehealth Platforms.
2 Not profitable at operating income level
Op Inc LTMOperating Income, Last Twelve Months is -0.1 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -0.1%
3 Expensive valuation multiples
P/CFOPrice/(Cash Flow from Operations). CFO is cash before capital expenditures. is 63x, P/EPrice/Earnings or Price/(Net Income) is 108x
4 Yield minus risk free rate is negative
ERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -3.2%
5 Key risks
TALK key risks include [1] challenges in maintaining and expanding its network of therapists, Show more.

Valuation, Metrics & Events

TALK Stock


Why The Stock Moved


Qualitative Assessment

AI Generated Analysis | Feedback

Talkspace (TALK) experienced significant developments during the approximate period from August 31, 2025, to December 18, 2025, which contributed to its stock movement. 1. Strong Q2 2025 Financial Performance: Talkspace reported robust second-quarter 2025 results, with total revenue increasing 18% year-over-year to $54.3 million, primarily driven by a 35% growth in Payor revenue. The company also achieved a positive Adjusted EBITDA of $2.3 million. This financial health and growth in a key segment likely instilled investor confidence. 2. Strategic Partnership for Enhanced Patient Matching: In August 2025, Talkspace announced a collaboration with Outcome Referrals to enhance its patient-matching capabilities. This partnership aimed to improve the alignment between providers and patient needs, which Talkspace identified as crucial for driving better clinical outcomes. This move could signal an effort to improve service quality and patient retention.

Show more

Stock Movement Drivers

Return vs. Risk


Price Returns Compared

 202020212022202320242025Total [1]
Returns
TALK Return-82%-69%316%22%15%
Peers Return-28%7%-3%-14%
S&P 500 Return16%27%-19%24%23%14%108%

Monthly Win Rates [3]
TALK Win Rate80%8%42%75%42%67% 
Peers Win Rate28%47%50%42%38% 
S&P 500 Win Rate58%75%42%67%75%73% 

Max Drawdowns [4]
TALK Max Drawdown-83%-70%-4%-35%-27% 
Peers Max Drawdown-51%-28%-50%-38% 
S&P 500 Max Drawdown-31%-1%-25%-1%-2%-15% 


[1] Cumulative total returns since the beginning of 2020
[2] Peers: TDOC, HIMS, AMWL, LFST, ACHC.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2025 data is for the year up to 12/17/2025 (YTD)

How Low Can It Go

Unique KeyEventTALKS&P 500
2022 Inflation Shock2022 Inflation Shock  
2022 Inflation Shock% Loss% Loss-95.2%-25.4%
2022 Inflation Shock% Gain to Breakeven% Gain to Breakeven1971.9%34.1%
2022 Inflation ShockTime to BreakevenTime to BreakevenNot Fully Recovered days464 days
2020 Covid Pandemic2020 Covid Pandemic  
2020 Covid Pandemic% Loss% Loss-10.9%-33.9%
2020 Covid Pandemic% Gain to Breakeven% Gain to Breakeven12.2%51.3%
2020 Covid PandemicTime to BreakevenTime to Breakeven66 days148 days

Compare to OMCL, BEAT, CARL, HTFL, VEEV


In The Past

Talkspace's stock fell -95.2% during the 2022 Inflation Shock from a high on 2/10/2021. A -95.2% loss requires a 1971.9% gain to breakeven.

Preserve Wealth

Limiting losses and compounding gains is essential to preserving wealth over time.

Asset Allocation

Actively managed asset allocation strategies protect wealth. Learn more.

About Talkspace (TALK)

Better Bets than Talkspace (TALK)

Latest Trefis Analyses

Title
0ARTICLES

Trade Ideas

Select past ideas related to TALK. For more, see Trefis Trade Ideas.

Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
16.8%16.8%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-6.4%-6.4%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
5.2%5.2%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
3.4%3.4%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
14.4%14.4%-5.1%
Unique KeyDateTickerCompanyCategoryTrade Strategy6M Fwd Rtn12M Fwd Rtn12M Max DD
CRL_11142025_Dip_Buyer_FCFYield11142025CRLCharles River Laboratories InternationalDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
16.8%16.8%-3.7%
GDRX_11142025_Dip_Buyer_High_CFO_Margins_ExInd_DE11142025GDRXGoodRxDip BuyDB | CFO/Rev | Low D/EDip Buy with High Cash Flow Margins
Buying dips for companies with significant cash flows from operations and reasonable debt / market cap
-6.4%-6.4%-11.8%
ASTH_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025ASTHAstrana HealthDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
5.2%5.2%-5.5%
SGRY_11142025_Dip_Buyer_High_FCF_Yield_ExInd_DE_RevG11142025SGRYSurgery PartnersDip BuyDB | FCF Yield | Low D/EDip Buy with High Free Cash Flow Yield
Buying dips for companies with significant free cash flow yield (FCF / Market Cap) and reasonable debt / market cap
3.4%3.4%-1.4%
TFX_11072025_Dip_Buyer_FCFYield11072025TFXTeleflexDip BuyDB | FCFY OPMDip Buy with High FCF Yield and High Margin
Buying dips for companies with high FCF yield and meaningfully high operating margin
14.4%14.4%-5.1%

Recent Active Movers

Recent Active Movers

More From Trefis

Peer Comparisons for Talkspace

Peers to compare with:

Financials

TALKTDOCHIMSAMWLLFSTACHCMedian
NameTalkspaceTeladoc .Hims & H.American.LifeStan.Acadia H. 
Mkt Price3.457.2534.974.706.9114.537.08
Mkt Cap0.61.37.90.12.71.31.3
Rev LTM2152,5282,2112651,3683,2661,789
Op Inc LTM-0-179115-12374444
FCF LTM-2140119-64119-34759
FCF 3Y Avg-1015399-13439-25215
CFO LTM7293325-62151335222
CFO 3Y Avg-5305186-12072308129

Growth & Margins

TALKTDOCHIMSAMWLLFSTACHCMedian
NameTalkspaceTeladoc .Hims & H.American.LifeStan.Acadia H. 
Rev Chg LTM18.4%-2.4%78.0%4.3%13.4%4.6%9.0%
Rev Chg 3Y Avg22.1%3.0%71.0%-0.6%18.6%9.0%13.8%
Rev Chg Q25.3%-2.2%49.2%-7.8%16.3%4.4%10.4%
QoQ Delta Rev Chg LTM5.9%-0.6%9.8%-1.8%3.9%1.1%2.5%
Op Mgn LTM-0.1%-7.1%5.2%-46.4%0.5%13.6%0.2%
Op Mgn 3Y Avg-10.0%-7.6%1.2%-78.7%-8.4%16.2%-8.0%
QoQ Delta Op Mgn LTM1.0%0.2%-1.0%5.9%0.5%-1.0%0.3%
CFO/Rev LTM3.4%11.6%14.7%-23.4%11.0%10.3%10.6%
CFO/Rev 3Y Avg-4.8%11.9%11.8%-46.0%5.5%10.2%7.8%
FCF/Rev LTM-0.8%5.5%5.4%-24.3%8.7%-10.6%2.3%
FCF/Rev 3Y Avg-6.9%6.0%6.9%-51.2%2.6%-7.8%-2.1%

Valuation

TALKTDOCHIMSAMWLLFSTACHCMedian
NameTalkspaceTeladoc .Hims & H.American.LifeStan.Acadia H. 
Mkt Cap0.61.37.90.12.71.31.3
P/S2.10.55.80.41.60.71.1
P/EBIT-4,247.1-6.0111.6-0.8329.18.23.7
P/E108.1-6.196.0-0.9-233.420.910.0
P/CFO63.44.739.5-1.614.16.710.4
Total Yield0.9%-16.3%1.0%-113.7%-0.4%4.8%0.2%
Dividend Yield0.0%0.0%0.0%0.0%0.0%0.0%0.0%
FCF Yield 3Y Avg-2.9%9.0%2.2%-77.6%1.8%-7.6%-0.5%
D/E0.00.80.10.10.21.10.2
Net D/E-0.20.20.0-2.00.11.00.1

Returns

TALKTDOCHIMSAMWLLFSTACHCMedian
NameTalkspaceTeladoc .Hims & H.American.LifeStan.Acadia H. 
1M Rtn8.5%7.4%-1.7%18.7%10.6%-7.2%7.9%
3M Rtn35.8%-8.2%-30.5%-27.6%34.2%-33.7%-17.9%
6M Rtn24.5%3.4%-42.7%-31.0%40.2%-32.5%-13.8%
12M Rtn5.8%-28.0%12.4%-44.4%-7.6%-63.3%-17.8%
3Y Rtn303.5%-73.2%417.3%-92.9%36.6%-82.8%-18.3%
1M Excs Rtn7.8%6.7%-2.4%18.0%9.8%-7.9%7.2%
3M Excs Rtn28.8%-13.6%-39.1%-29.6%27.3%-35.5%-21.6%
6M Excs Rtn12.2%-9.0%-55.1%-43.4%27.8%-44.9%-26.2%
12M Excs Rtn-5.2%-41.5%5.4%-60.5%-14.7%-75.3%-28.1%
3Y Excs Rtn314.0%-142.5%318.6%-161.2%-30.2%-150.9%-86.4%

Financials

Segment Financials

Revenue by Segment

$ Mil202420232022
Single Segment150120114
Total150120114


Price Behavior

Short Interest

Short Interest: As Of Date11282025
Short Interest: Shares Quantity6,958,791
Short Interest: % Change Since 111520251.0%
Average Daily Volume1,049,416
Days-to-Cover Short Interest6.63
Basic Shares Quantity166,190,495
Short % of Basic Shares4.2%

Earnings Returns History

Expand for More

 Forward Returns
Earnings Date1D Returns5D Returns21D Returns
10/30/20254.7%24.2%13.0%
8/5/2025-3.8%4.2%12.3%
5/6/20250.5%-1.6%5.6%
2/20/2025-14.8%-25.9%-28.2%
10/29/202418.2%16.4%23.0%
8/6/2024-1.7%-5.6%6.8%
5/7/2024-15.4%-10.4%-16.4%
2/22/202417.9%23.1%48.7%
...
SUMMARY STATS   
# Positive8812
# Negative10106
Median Positive11.8%16.5%15.2%
Median Negative-7.7%-10.1%-25.3%
Max Positive19.7%24.2%48.7%
Max Negative-36.3%-38.6%-43.4%

SEC Filings

Expand for More

Report DateFiling DateFiling
93020251106202510-Q 9/30/2025
6302025808202510-Q 6/30/2025
3312025509202510-Q 3/31/2025
12312024312202510-K 12/31/2024
93020241107202410-Q 9/30/2024
6302024808202410-Q 6/30/2024
3312024509202410-Q 3/31/2024
12312023313202410-K 12/31/2023
93020231107202310-Q 9/30/2023
6302023802202310-Q 6/30/2023
3312023510202310-Q 3/31/2023
12312022310202310-K 12/31/2022
93020221108202210-Q 9/30/2022
6302022809202210-Q 6/30/2022
3312022505202210-Q 3/31/2022
12312021225202210-K 12/31/2021